Sorrento Therapeutics Inc (SRNE)

Sorrento Therapeutics Inc (SRNE)

Charts by TradingView

Pricing is indicative. Past performance is not a reliable indicator of future results. Log in to see latest markets data.

Sorrento Therapeutics Inc (SRNE) Profile

Sorrento Therapeutics, Inc. engages in the research, development and manufacture of biopharmaceutical products. It focuses on therapies to treat specific stages in the evolution of cancer, from elimination to equilibrium and escape which include biosimilars, immuno-oncology antibodies, cellular therapy, cell internalizing antibodies, and antibody-drug conjugates. It operates through Sorrento Therapeutics and Scilex segments. The company was founded by Henry H. Ji in 1989 and is headquartered in San Diego, CA.

Sorrento Therapeutics, Inc. has 502 total employees across all of its locations and generates $39.99 m.illion in sales (USD Market Cap1.501B USD Stock price: SRNE (NASDAQ) $4.90 +0.03 (+0.62%) Sorrento Therapeutics Inc (SRNE.xnas )News On Monday, the company said that initial lab testing of COVISTIX - the company’s Covid-19 rapid antigen detection test - showed that in addition to being able to detect the original SARS-CoV-2 virus and other significant variants of concern (VOCs) including the Delta and Delta-plus strains, the test can identify the Omicron variant. Not only that, but the lab results show that it could detect the Omicron N protein at a much lower level than other Emergency Use Authorization (EUA) approved commercially-available tests.

Sorrento Therapeutics Inc (SRNE.xnas) Analysis Sorrento Therapeutics (SRNE) might not receive widespread coverage on Wall Street, but one analyst has repeatedly banged the drum for the drugmaker.

H.C. Wainwright’s Ram Selvaraju thinks SRNE stocks are significantly undervalued. Backing his Buy rating with a $26 price target, the analyst sees stocks climbing ~430% in the year ahead. Subsidiaries; ACEA Therapeutics, SILEX pharmaceuticals, bioserv, Smart Pharm Therapeutics, ark animal health,

Holding cost
Trading hours in US Eastern Time
10:00 - 18:30
10:00 - 18:30
10:00 - 18:30
10:00 - 18:30
10:00 - 18:30

Start Trading Sorrento Therapeutics Inc (SRNE)
with a Market Leader Today

Share CFD Trading FAQ

Each investor owning shares of a company is also owning fragments of the company. A quite simple way to explain what a stock is is basically when a company divides itself into several shares and then it makes a part of these equities available to the public, at a price. Each investor owning shares of a company is owning fragments of the company.

While shares represent units of ownership within a company Contracts for Difference (CFDs) allow traders to speculate on the future share price fluctuations of an underlying asset. Thus when trading CFDs traders do not physically own the underlying asset. CFDs are available for a range of underlying assets, such as shares, commodities, and foreign exchange, and indices.

6 Reasons to Trade Share
CFDs with FP Markets

An Australian-regulated
forex & CFD broker

Go Long or Short

Increase your ability to profit in all market conditions Leverage options up to 20:1

Direct Market Access (DMA) Execution

Real-time, transparent share prices Control, Functionality and deep liquidity Full Market depth & see your orders in the queue

Advanced Platforms
& Technology

MT4, MT5, Webtrader & Iress with superior client portal

24/5 Multilingual
Customer Support

Award winning support & personal account managers

Global Exposure

Low margins and competitive commission +10,000 products on global stocks across 4 continents

Earn Dividends

On long positions No ownership of physical shares necessary

Start Trading
in Minutes

Open an account now

bullet Access 10,000+ financial instruments
bullet Auto open & close positions
bullet News & economic calendar
bullet Technical indicators & charts
bullet Many more tools included

By supplying your email you agree to FP Markets privacy policy and receive future marketing materials from FP Markets. You can unsubscribe at any time.

Get instant Updates in Telegram
Sitemap | © FP Markets 2022